12th Berlin Conference on Life Sciences

Novel Antimicrobials and AMR Diagnostics 2019

14–15 March 2019

Berlin

   

Berlin Conference on Novel Antimicrobials

Big drugs for bad bugs

The Berlin Conference on Life Sciences "Novel Antimicrobials & Diagnostics" series aims to serve as a platform for SMEs, startups, big pharma, academia, investors and governmental institutions to pick up innovative ideas, to address the specific challenges faced by SMEs and to discuss strategies to bring new antimicrobial treatments and diagnostics to the patient. 

The last year's focus on the discovery and development of novel antimicrobials & AMR diagnostics will be complemented by a policy forum and partnering opportunities in this one-and-a-half-day event in 2019. We will expect 350+ attendees and topics will cover:

  • Antimicrobial Market – Industry overview, SME engagement & financial insights
  • Technology Perspective – New approaches to combat AMR in humans and animals
  • Diagnostic Challenge – innovatons to detect multiple drug resistance in humans and animals
  • Legal Environment & Reimbursement – The challenges of bringing antimicrobials to the market
  • R&D Trends – Research and development beyond antibiotics and diagnostics & public-private partnerships
  • Policy Forum – Global strategies to fight AMR and challenges of investors/companies support
  • Start-up Pitch & Investor's talk – Pitching opportunities for investors, funders and start-ups & discussion about business models in the field of AMR therapeutics and diagnostics
  • Poster Session & Exhibition  – Showcase of promising academic innovations and highlight of relevant initiatives, networks, companies and service providers in the field of AMR
  • 1-to-1 Meetings with Investors – Plattform for networking with all relevant AMR investors from the public and private sector


Supporting partners

Media partner